AI assistant
DAVITA INC. — Director's Dealing 2014
Feb 21, 2014
30643_dirs_2014-02-21_3bc695a8-53f1-46b4-9528-cd3c3ad05832.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2014-02-19
Reporting Person: DAVIDSON CAROL ANTHONY (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-02-19 | Common Stock | M | 22500 | $37.055 | Acquired | 27888 | Direct |
| 2014-02-19 | Common Stock | F | 12476 | $66.83 | Disposed | 15412 | Direct |
| 2014-02-19 | Common Stock | S | 10024 | $66.0381 | Disposed | 5388 | Direct |
| 2014-02-19 | Common Stock | M | 24000 | $42.465 | Acquired | 29388 | Direct |
| 2014-02-19 | Common Stock | F | 15251 | $66.83 | Disposed | 14137 | Direct |
| 2014-02-19 | Common Stock | S | 8749 | $66.2240 | Disposed | 5388 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-02-19 | Stock Appreciation Right | $37.055 | M | 22500 | Disposed | 2015-12-02 | Common Stock (22500) | Direct |
| 2014-02-19 | Stock Appreciation Right | $42.465 | M | 24000 | Disposed | 2017-06-11 | Common Stock (24000) | Direct |
Footnotes
F1: Represents the weighted average sale price of $66.0381. The range of prices for the sale of these shares was $65.98 - $66.09. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
F2: Represents the weighted average sale price of $66.2240. The range of prices for the sale of these shares was $66.09 - $66.41. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
F3: Stock Appreciation Rights, granted on December 2, 2010 pursuant to the DaVita Inc. 2002 Equity Compensation Plan, (as amended and restated, the "DaVita HealthCare Partners Inc. 2011 Incentive Award Plan," effective June 6, 2011), which vested 25% each on the first four anniversaries of the grant date.
F4: Stock Appreciation Rights, granted on June 11, 2012 pursuant to the DaVita HealthCare Partners Inc. 2011 Incentive Award Plan, which vests 100% on the first anniversary of the grant date.